Access cutting-edge hypoxic ischemic encephalopathy treatment through this early phase 1 clinical trial at a research site in Gainesville. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Gainesville location
Preparing your pre-screening questions…
Access hypoxic ischemic encephalopathy specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related hypoxic ischemic encephalopathy treatment provided free
Check if you qualify for this hypoxic ischemic encephalopathy clinical trial in Gainesville, FL
No-Cost Study Care
Local to Gainesville
Convenient for FL residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Hypoxic-Ischemic Encephalopathy (HIE) occurs in 20 per 1000 births. Only 47% of neonates treated with the state of the art therapy (induced systemic hypothermia) have normal outcomes. Therefore, other promising therapies that potentially work in synergy with hypothermia to improve neurologic outcomes need to be tested. One potential agent is melatonin. Melatonin is a naturally occurring substance produced mainly from the pineal gland. Melatonin is widely known for its role in regulating the circadian rhythm, but it has many other effects that may benefit infants with HI injury. Melatonin serves as a free radical scavenger, decreases inflammatory cytokines, and stimulates anti-oxidant enzymes. Therefore, melatonin may interrupt several key components in the pathophysiology of HIE, in turn minimizing cell death and improving outcomes. The research study will evaluate the neuroprotective properties and appropriate dose of Melatonin to give to infants undergoing therapeutic hypothermia for hypoxic ischemic encephalopathy.
Sponsor: University of Florida
Yes, this clinical trial (NCT02621944) has an active research site in Gainesville, FL that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for hypoxic ischemic encephalopathy treatment options in Gainesville, FL, this clinical trial (NCT02621944) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Gainesville research site is actively enrolling participants for this early phase 1 clinical trial. You'll receive care from experienced hypoxic ischemic encephalopathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all hypoxic ischemic encephalopathy clinical trials near you to find additional studies recruiting in your area.
See all heart attack clinical trials recruiting in Gainesville — not just this study.
Browse Heart Attack Trials in Gainesville →